Prevalence and prognostic factors for aortic dilatation in giant cell arteritis - a longitudinal study.


Journal

Seminars in arthritis and rheumatism
ISSN: 1532-866X
Titre abrégé: Semin Arthritis Rheum
Pays: United States
ID NLM: 1306053

Informations de publication

Date de publication:
08 2021
Historique:
received: 22 10 2020
revised: 16 11 2020
accepted: 19 11 2020
pubmed: 5 12 2020
medline: 25 2 2023
entrez: 4 12 2020
Statut: ppublish

Résumé

Predictive data for the development of aortic dilatation (AD) in giant-cell arteritis (GCA) are controversial. The aim was to investigate by computed tomography (CT) the prevalence of AD in a consecutive cohort of GCA patients and controls, and to identify possible predictors for AD. GCA patients and controls were identified by electronic search and underwent aortic contrast enhanced CT defining AD by aortic diameter adjusted to age, gender and body surface area. Pulse-wave velocity, intima-media thickness (IMT) and laboratory studies including lymphocyte subsets were conducted identifying potential factors associated with AD. Clinical and laboratory parameters at disease onset, occurrence of aortic rupture/dissection before and up to five years after study visit were retrieved by chart review. 144 GCA patients and 115 controls were included. GCA patients developed more frequently AD of the ascending and thoracic descending aorta compared to controls (OR 2.60, p = 0.016; OR 3.65, p = 0.005, respectively). Factors associated with AD development of thoracic descending aorta, but not of the ascending aorta, were higher percentages of circulating CD3+CD4+ cells, higher CD4/CD8 ratio, presence of polymyalgia rheumatica and increased carotid IMT at disease onset (OR range 1.10-3.11, all with p < 0.05). During follow-up, no GCA patient required surgical aortic repair or suffered aortic rupture/dissection. Thoracic but not abdominal ADs occur more commonly in GCA patients, however, the subsequent risk for aortic repair, rupture or dissection is low. Changes of T-cell subsets, presence of polymyalgia rheumatica and increased carotid IMT at disease onset are associated with AD development.

Identifiants

pubmed: 33272608
pii: S0049-0172(20)30278-X
doi: 10.1016/j.semarthrit.2020.11.003
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

911-918

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no conflict of interest

Auteurs

Philipp Jud (P)

Division of Angiology, Department of Internal Medicine, Medical University of Graz, Graz, Austria. Electronic address: philipp.jud@medunigraz.at.

Nicolas Verheyen (N)

Division of Cardiology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.

Christian Dejaco (C)

Division of Rheumatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria; Hospital of Brunico (SABES-ASDAA), Department of Rheumatology, Brunico, Italy.

Elke Haas (E)

Division of Angiology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.

Dieter Szolar (D)

Diagnostikum Graz Süd-West, Graz, Austria.

Andreas Meinitzer (A)

Institute of Medical and Chemical Laboratory Diagnostics, Medical University Graz, Graz, Austria.

Christina Duftner (C)

Department of Internal Medicine, Medical University of Innsbruck, Innsbruck, Austria.

René Thonhofer (R)

Department of Internal Medicine, State Hospital Muerzzuschlag, Muerzzuschlag, Austria.

Paul Gressenberger (P)

Division of Angiology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.

Marianne Brodmann (M)

Division of Angiology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.

Franz Hafner (F)

Division of Angiology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH